Researchers reveal that immune system like a turbo-charged hybrid car

(Medical Xpress)—Trinity College Dublin scientists have made a significant breakthrough in understanding the immune system that could lead to new treatments for diseases such as sepsis and Type 2 diabetes. A team led by Professor of Biochemistry, Luke O'Neill of the School of Biochemistry and Immunology in the Trinity Biomedical Sciences Institute has revealed that during an infection, immune cells switch their "engine" from the more sedate "battery" power, to using the equivalent of petrol to supercharge the engine needed to fight the infection. The work has just been published in the international leading science journal Nature.

In the process of metabolism, the immune system burns food for energy and uses the products to make molecules to energise and keep the body healthy, as well as defending it at a time of infection. Much research has been done in this area, but according to Professor O'Neill, this new research defines the process of metabolism in great detail.

"Importantly we have found that a product of this metabolic change called 'succinate', feeds back to the system and leads to further stimulation, in a manner akin to turbo-charging from an engine's exhaust. This is the part of the process that could lead to new therapies for diseases where the immune system is out of control. Such loss of control happens in overwhelming infection as occurs in sepsis, or in diseases such as or . We think this system is in overdrive in these diseases," says O'Neill. The observation was made because of work into Type 2 diabetes, where rise and stimulate macrophages to become inflamed, promoting resistance to insulin, the hallmark of this disease.

"We have managed to demonstrate protection from death in by interfering with this process with a drug, giving us hope that our work might have potential for the prevention of death during bacterial infections," says Dr Gillian Tannahill, first author of the study. The findings may also have relevance for the treatment of Type 2 diabetes.

More information: Article: Succinate is an inflammatory signal that induces IL-1b through HIF-1a, DOI: 10.1038/nature11986

Related Stories

Scientists discover new 'off switch' in immune response

Feb 28, 2012

Scientists from Trinity College Dublin have discovered a new 'off switch' in our immune response which could be boosted in diseases caused by over-activation of our immune system, or blocked to improve vaccines. The findings ...

Recommended for you

Study unlocks basis of key immune protein's two-faced role

15 hours ago

A Brigham and Women's Hospital-led team has identified a long sought-after partner for a key immune protein, called TIM-3, that helps explain its two-faced role in the immune system—sometimes dampening it, other times stimulating ...

Profilin can induce severe food-allergic reactions

Nov 25, 2014

(HealthDay)—Profilins are complete food allergens in food-allergic patient populations that are exposed to high levels of grass pollen, according to a study published in the December issue of Allergy.

Structured education program beneficial for anaphylaxis

Nov 21, 2014

(HealthDay)—A structured education intervention improves knowledge and emergency management for patients at risk for anaphylaxis and their caregivers, according to a study published online Nov. 19 in Allergy.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.